Shares of Dogwood Therapeutics Inc. (DWTX), a development-stage biotechnology company developing new medicines to treat pain and fatigue-related disorders, are up more than 50% at $2.94 in premarket trading Tuesday.The company's pipeline includes Halneuron for chemotherapy-induced neuropathic pain; IMC-1 for the treatment of fibromyalgia; and IMC-2 to treat Long COVID sequelae.-- Halneuron, a non...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.